Roads of Drug Resistance in Acute Myeloid Leukemia – Is It a Dead End?
Acute myeloid leukemia (AML) is a biologically and clinically heterogeneous neoplasm, which is characterized by abnormal proliferation, impaired apoptosis, and differentiation of leukemic immature cells. Nowadays, the first line treatment of AML is the chemotherapy regimen, which combines both cytos...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/85350 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Roads of Drug Resistance in Acute Myeloid Leukemia – Is It a Dead End?
- Therapy-Related Acute Myeloid Leukemias
- The Role of <em>BAALC</em> Gene in the Transformation of Myeloid Progenitor Cells to Acute Myeloid Leukemia
- Mechanisms of Resistence of New Target Drugs in Acute Myeloid Leukemia
- Pediatric Acute Myeloid Leukemia
- Therapy of Acute Myeloid Leukemia
- Treatment of Myelodysplastic Syndrome and Acute Myeloid Leukemia by Immunomodulatory and Epigenetic Drugs